K2 Investment Partners logo

K2 Investment Partners

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

K2 Investment Partners LLC is a private equity firm specializing in both direct and indirect secondary investments

Investor Profile

K2 Investment Partners has made 10 investments, with 4 in the past 12 months and 10% as lead.

Stage Focus

  • Series B (40%)
  • Series A (30%)
  • Series C (10%)
  • Series Unknown (10%)
  • Seed (10%)

Country Focus

  • South Korea (80%)
  • United States (20%)

Industry Focus

  • Software
  • Artificial Intelligence (Ai)
  • Manufacturing
  • Biotechnology
  • Pharmaceutical
  • Cloud Management
  • Medical
  • Digital Media
  • Media And Entertainment
  • Ux Design
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does K2 Investment Partners frequently co-invest with?

Industrial Bank of Korea
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
TS Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
LB Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
SBVA
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
Mirae Asset Daewoo
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
SV
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 1
Company K Partners
Asia, Seoul-t'ukpyolsi, South Korea, Ilsangu
Co-Investments: 3
Pathfinder H
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1

What are some of recent deals done by K2 Investment Partners?

ENERZAi

Seoul, Seoul-t'ukpyolsi, South Korea

ENERZAi is an AI technology company that provides MCU, CPU, and application processor services.

Artificial Intelligence (AI)Machine LearningRoboticsWearables
Series UnknownMay 14, 2025
Amount Raised: $5,468,199
Prazer Therapeutics

Seoul, Seoul-t'ukpyolsi, South Korea

Prazer Therapeutics is a biotechnology company that generates novel therapeutics for refractory diseases.

BiotechnologyPharmaceuticalTherapeutics
Series BApr 1, 2025
Amount Raised: $19,728,977
Imagoworks

Seocho, Seoul-t'ukpyolsi, South Korea

Imagoworks specializes in artificial intelligence and cloud-based 3D dental and medical software.

Artificial Intelligence (AI)Cloud ManagementMedicalSoftware
Series CDec 31, 2024
Amount Raised: $15,616,415
EASYWITH

Yeoksamdong, Seoul-t'ukpyolsi, South Korea

Easywith is a media research and development company design and produces creative content using new visuals and ideas.

Digital MediaMedia and EntertainmentUX Design
Series UnknownDec 23, 2024
Amount Raised: $5,514,921
AIGEN Sciences

Seoul, Seoul-t'ukpyolsi, South Korea

AIGEN Sciences is an AI drug discovery platform that provides drug research and development services.

Artificial Intelligence (AI)BiotechnologyPharmaceuticalProduct Research
Series AOct 16, 2024
Amount Raised: $8,794,744
ADRO

Yongsin, Kyonggi-do, South Korea

Aerodynamic Hardware and Software Solutions

AutomotiveManufacturingSoftware
Series AJun 19, 2024
Amount Raised: $3,906,388
GenEdit

South San Francisco, California, United States

GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.

BiotechnologyGeneticsPharmaceuticalTherapeutics
Series AJan 23, 2024
Amount Raised: $24,000,000
Point2 Technology

Seoul, Seoul-t'ukpyolsi, South Korea

Point2 Technology develops a dielectric waveguide for high speed interconnect for both datacenter applications.

ElectronicsIndustrial ManufacturingManufacturing
Series BMay 25, 2022
Amount Raised: $22,000,000
Path

Seoul, Seoul-t'ukpyolsi, South Korea

Path provides an AI platform for managing study habits.

Artificial Intelligence (AI)EdTechEducation
SeedDec 16, 2021
Amount Raised: $5,732,471
WhaTap Labs

Seocho, Seoul-t'ukpyolsi, South Korea

WhaTap Labs is a Korean company providing B2B service monitoring engine.

Application Performance ManagementB2BSoftware
Series BJun 15, 2021
Amount Raised: $10,742,762